about
Expression and prognostic value of the WEE1 kinase in gliomas.Small cell glioblastoma or small cell carcinoma: a case report and review of the literature.APNG as a prognostic marker in patients with glioblastoma.Clinical value of CD133 and nestin in patients with glioma: a population-based study.Glioma Cells in the Tumor Periphery Have a Stem Cell PhenotypeWhat is the clinical value of cancer stem cell markers in gliomas?Tumor-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumor subtype.Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.High levels of c-Met is associated with poor prognosis in glioblastoma.The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.Trends in tumors in the central nervous system in elderly in Denmark, 2008-2012.Novel approaches for quantifying protein biomarkers in gliomas: benefits and pitfalls.Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.Expression and prognostic value of JAM-A in gliomas.A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).STEM-13EXPRESSION OF STEM CELL, PROLIFERATION AND CHEMORESISTANCE MARKERS IN GLIOMA CELLS IN THE TUMOR PERIPHERY.TMIC-18TUMOR-ASSOCIATED MICROGLIA/MACROPHAGES ARE ASSOCIATED WITH POOR PROGNOSIS IN HIGH-GRADE GLIOMAS AND CONTRIBUTE TO THE GLIOBLASTOMA STEM CELL-LIKE NICHES.P04.16THE BIOMARKER POTENTIAL OF MGMT PROTEIN EXPRESSION IN GLIOBLASTOMA IS IMPROVED BY EXCLUSION OF NON-TUMOR CELLS.MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.P04.09THE PROGNOSTIC POTENTIAL OF CD133 AND NESTIN IN A POPULATION-BASED COHORT OF GLIOMA PATIENTS.Evaluation of the proliferation marker Ki-67 in gliomas: Interobserver variability and digital quantification.Prognostic value of Musashi-1 in gliomas.Aberrant neuronal differentiation is common in glioma but is associated neither with epileptic seizures nor with better survivalPosttreatment Effect of MGMT Methylation Level on Glioblastoma SurvivalP04.25 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomasP01.083 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomasP01.114 Expression and prognostic value of the immune checkpoint molecule galectin-9 in glioblastomasP04.41 Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomasPATH-52. TIME-VARYING EFFECT OF MGMT METHYLATION LEVEL ON SURVIVAL OF GLIOBLASTOMA MULTIFORME
P50
Q30570389-BDBEF2BA-BD95-4D33-BA37-4E3E2C1A7403Q30651905-4225E6B9-7F3E-4804-9B6C-C362FEFBC85EQ33852894-3901EFAF-DBF9-4E74-89CF-81882FE0A99FQ34028947-4D021B30-C365-473F-A4B2-5689210C34D6Q36015831-47CC3A94-E4B3-4420-B415-B2F9108E0E0AQ38081776-45F3A3B5-2C72-46EA-B7AB-D36146B781DCQ38647050-7AD136D1-FE96-436A-9E97-877C13423A88Q38675705-F6C794DB-296C-44DE-99C3-E7688B188834Q38896220-B76A6CDC-34B6-4299-A558-C2E1A9F3038BQ39118596-6B11CBBE-D70F-4F8C-BBA1-00B7BF6B0107Q40093333-0B043AF6-1239-4EC9-8205-E056EF23B932Q40226917-D8A11233-A20D-48B4-89DD-C2820BCDC6ECQ40939911-DEFEA07D-FE59-469A-94F5-102F48DCA46DQ41512201-879C540A-90C3-4247-B601-B796051D43B7Q44341014-7C892090-A0AE-4998-A4BB-D8E7CB2CA443Q45066734-D70DF328-4530-4392-872D-7D727DD69AB2Q45835683-6AF3EA9E-9392-4500-B6E8-3C132A258D21Q45836107-77583458-5A4B-4A4A-8DC9-D1AC02177470Q45941618-8F1F82FF-683F-4A31-820A-B59C866F9333Q46677764-D25147C0-D1EB-4A46-B146-3F68CEBB0E76Q46881100-365F5F0A-B7BF-4DD0-93C4-CF4D82A77063Q55259357-0FC357D9-AFA9-492F-9BEC-571C422028B7Q55461475-2E8C6FDF-BE15-4B88-9C07-144087E02C6AQ57296293-B575A135-147D-4EA4-9869-862B17896444Q91779591-E45A619C-8697-4446-A223-AF24AC2EAF94Q94086671-347AD319-3EDC-4798-B70D-BE455C69CE63Q94087230-FB659E60-6172-4361-BC61-DFEEBB510BA4Q94087369-39CAA303-550E-4ACA-B027-CFC7F6D66993Q94087942-B1334F60-FF1C-4A66-B270-839382CD1F8FQ94407559-3B82EB85-D2BC-4682-BC45-AB51FF52794D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Rikke Hedegaard Dahlrot
@en
Rikke Hedegaard Dahlrot
@nl
type
label
Rikke Hedegaard Dahlrot
@en
Rikke Hedegaard Dahlrot
@nl
prefLabel
Rikke Hedegaard Dahlrot
@en
Rikke Hedegaard Dahlrot
@nl
P31
P496
0000-0003-1538-4361